0,773  0,003  Mcl-1 antagonist
0,787  0,018  Apoptosis agonist
0,711  0,008  Mutagenic
0,693  0,007  12-Lipoxygenase inhibitor
0,651  0,009  CTGF expression inhibitor
0,639  0,010  UGT1A9 substrate
0,637  0,012  Sensitization
0,618  0,021  15-Lipoxygenase inhibitor
0,599  0,009  UGT1A6 substrate
0,580  0,013  Antioxidant
0,587  0,022  CYP2C9 substrate
0,549  0,012  FMO1 substrate
0,566  0,035  Transcription factor NF kappa B inhibitor
0,567  0,041  Caspase 9 stimulant
0,545  0,027  Aldehyde oxidase inhibitor
0,529  0,015  Lipoxygenase inhibitor
0,530  0,020  CYP1A2 substrate
0,538  0,033  Antileukemic
0,503  0,008  Antineoplastic (small cell lung cancer)
0,517  0,022  Cytotoxic
0,514  0,019  Antifungal
0,503  0,010  Antihypoxic
0,496  0,005  Lipid peroxidase inhibitor
0,499  0,019  Chemopreventive
0,489  0,016  Antineoplastic (non-Hodgkin's lymphoma)
0,497  0,029  Respiratory analeptic
0,484  0,019  Antineoplastic (multiple myeloma)
0,464  0,004  Neurotrophic factor enhancer
0,484  0,026  Antineoplastic (melanoma)
0,468  0,012  Pyruvate kinase inhibitor
0,456  0,005  Antiviral (Influenza A)
0,452  0,004  Heat shock protein 90 alpha antagonist
0,456  0,018  UGT2B4 substrate
0,463  0,033  CYP2C19 substrate
0,476  0,048  Antibacterial
0,437  0,010  Contraceptive
0,438  0,024  Antiprotozoal (Leishmania)
0,428  0,027  Antineoplastic (non-small cell lung cancer)
0,410  0,011  Melanin inhibitor
0,411  0,014  Antineoplastic (bladder cancer)
0,400  0,004  Heat shock protein 90 antagonist
0,403  0,010  Antiviral (Influenza)
0,486  0,094  Antiinflammatory
0,433  0,047  CYP2C19 inhibitor
0,415  0,035  Analeptic
0,394  0,015  Antiviral (HIV)
0,374  0,004  Estrogen receptor alpha antagonist
0,388  0,018  Anesthetic general
0,436  0,069  Antineoplastic (breast cancer)
0,368  0,004  TRPA1 agonist
0,407  0,050  Prostate cancer treatment
0,375  0,018  Skin irritative effect
0,414  0,059  CYP3A4 substrate
0,357  0,006  UGT2B9 substrate
0,355  0,006  SULT1A3 substrate
0,427  0,078  Ca2+/calmodulin-dependent protein kinase kinase A inhibitor
0,411  0,063  Antineoplastic (lung cancer)
0,442  0,098  Alpha-glucosidase inhibitor
0,379  0,040  Antineoplastic (cervical cancer)
0,340  0,002  Bcl-xL inhibitor
0,376  0,042  Aryl hydrocarbon receptor agonist
0,364  0,030  Antiparasitic
0,339  0,008  Histone acetyltransferase inhibitor
0,364  0,036  Free radical scavenger
0,337  0,013  UGT2B15 substrate
0,352  0,031  Nitric oxide antagonist
0,339  0,019  UGT2B7 substrate
0,332  0,017  Skin whitener
0,316  0,003  Aldehyde dehydrogenase substrate
0,332  0,019  Antiseptic
0,363  0,052  AR expression inhibitor
0,315  0,005  Alcohol dehydrogenase substrate
0,323  0,017  Interferon gamma antagonist
0,328  0,026  UGT1A4 substrate
0,318  0,016  Monophenol monooxygenase inhibitor
0,309  0,010  Sulfotransferase substrate
0,403  0,114  DNA directed DNA polymerase inhibitor
0,403  0,118  DNA polymerase beta inhibitor
0,330  0,047  Antipyretic
0,336  0,054  Antihypercholesterolemic
0,335  0,057  Lipoprotein disorders treatment
0,312  0,036  Antihypertriglyceridemic
0,315  0,039  Antineoplastic (lymphocytic leukemia)
0,278  0,007  Contraceptive male
0,271  0,007  Contraceptive female
0,306  0,044  Carcinogenic
0,294  0,034  UGT1A1 substrate
0,312  0,055  Antineoplastic (glioma)
0,270  0,015  Antihyperlipoproteinemic
0,287  0,035  Antihelmintic
0,318  0,066  NOS3 expression inhibitor
0,306  0,054  NOS2 expression inhibitor
0,321  0,072  Apoptosis antagonist
0,314  0,065  Cardioprotectant
0,263  0,015  Antifungal enhancer
0,293  0,049  Antineoplastic (glioblastoma multiforme)
0,247  0,005  Aldose reductase inhibitor
0,315  0,074  Hepatic disorders treatment
0,292  0,053  Antineoplastic (lymphoma)
0,276  0,037  Hepatoprotectant
0,365  0,128  Antineoplastic (solid tumors)
0,247  0,010  SULT1A1 substrate
0,257  0,021  Acute respiratory distress syndrome (ARDS) treatment
0,274  0,038  RNA-directed DNA polymerase inhibitor
0,332  0,097  Immunosuppressant
0,240  0,007  NAD(P)H dehydrogenase (quinone) inhibitor
0,334  0,101  Antiprotozoal
0,246  0,013  Mannose-6-phosphate isomerase inhibitor
0,273  0,042  UDP-glucuronosyltransferase substrate
0,260  0,029  Acaricide
0,233  0,003  Purinergic P2X2 antagonist
0,311  0,084  Cholesterol antagonist
0,234  0,007  HIV-1 integrase (Strand Transfer) inhibitor
0,302  0,077  Sodium/bile acid cotransporter inhibitor
0,228  0,004  Bcl2 antagonist
0,294  0,071  Antineoplastic (pancreatic cancer)
0,319  0,097  Ulceration
0,233  0,012  Toll-Like receptor 2 antagonist
0,275  0,057  Hypolipemic
0,320  0,102  Calpain 2 inhibitor
0,248  0,031  UGT1A3 substrate
0,224  0,010  Estrogen antagonist
0,244  0,032  Protein-tyrosine phosphatase inhibitor
0,231  0,021  Aldehyde dehydrogenase inhibitor
0,218  0,008  HIV-1 integrase (3'-Processing) inhibitor
0,266  0,057  DNA synthesis inhibitor
0,249  0,040  Pneumotoxic
0,289  0,092  Bone diseases treatment
0,228  0,030  Phospholipase A2 inhibitor
0,284  0,087  Antineoplastic (colorectal cancer)
0,217  0,026  UGT2B10 substrate
0,271  0,086  Antineoplastic (colon cancer)
0,194  0,010  Actinic keratosis treatment
0,285  0,102  Thyroid hormone antagonist
0,211  0,031  Genotoxic
0,214  0,036  Phospholipase C inhibitor
0,214  0,037  Protein kinase stimulant
0,215  0,037  Muscular dystrophy treatment
0,304  0,128  TNF expression inhibitor
0,197  0,022  Antineoplastic antibiotic
0,195  0,021  Movement disorders treatment
0,248  0,073  Antineoplastic (liver cancer)
0,258  0,086  Antiosteoporotic
0,172  0,003  Catechol O-methyltransferase inhibitor
0,251  0,083  Chemoprotective
0,290  0,125  Antineoplastic (myeloid leukemia)
0,269  0,106  Thyroid hormone beta antagonist
0,168  0,004  SULT1A2 substrate
0,176  0,016  Porphobilinogen synthase inhibitor
0,208  0,048  Eye irritation, high
0,175  0,017  Beta glucuronidase inhibitor
0,224  0,068  Antineoplastic enhancer
0,179  0,024  Xanthine oxidase inhibitor
0,163  0,008  Alpha tubulin antagonist
0,193  0,039  Carcinogenic, group 3
0,187  0,034  Neurotrophic factor
0,173  0,021  UGT2B1 substrate
0,208  0,056  Antipruritic, non-allergic
0,190  0,046  ATPase inhibitor
0,176  0,032  Gout treatment
0,171  0,027  Coagulant
0,241  0,098  Radioprotector
0,248  0,105  Antipsoriatic
0,155  0,012  CDC25A inhibitor
0,148  0,007  5-Alpha-reductase inhibitor
0,269  0,129  GST A substrate
0,155  0,018  Aminoacyl-tRNA synthetase inhibitor
0,227  0,095  Proliferative diseases treatment
0,147  0,016  Estrogen receptor beta antagonist
0,228  0,098  Flavin-containing monooxygenase substrate
0,137  0,008  CDC25B inhibitor
0,170  0,043  Toll-Like receptor antagonist
0,141  0,014  Ornithine decarboxylase inhibitor
0,157  0,035  5-Lipoxygenase inhibitor
0,212  0,089  Cytostatic
0,184  0,062  3C-like protease (Human coronavirus) inhibitor
0,183  0,062  Antirickettsial
0,267  0,146  Antipruritic, allergic
0,226  0,105  Antineoplastic (ovarian cancer)
0,172  0,054  Amylase inhibitor
0,181  0,067  Succinate dehydrogenase inhibitor
0,136  0,022  UGT2B11 substrate
0,134  0,021  CYP2A6 inhibitor
0,254  0,144  Antineoplastic (endocrine cancer)
0,154  0,044  Protein-tyrosine phosphatase 1B inhibitor
0,149  0,040  Vanilloid 1 agonist
0,143  0,036  Mucolytic
0,173  0,066  Aldehyde oxidase substrate
0,214  0,108  Antiprotozoal (Trypanosoma)
0,224  0,119  Streptokinase A inhibitor
0,148  0,048  Antihemorrhagic
0,108  0,009  3(or 17)beta-hydroxysteroid dehydrogenase inhibitor
0,159  0,060  Antineoplastic (squamous cell carcinoma)
0,130  0,031  Anabolic
0,125  0,027  Paget's disease treatment
0,115  0,017  HIV-1 integrase inhibitor
0,130  0,035  DOPA decarboxylase inhibitor
0,164  0,072  Arachidonic acid antagonist
0,203  0,111  Calpain inhibitor
0,115  0,024  ATPase (Vacuolar H+) inhibitor
0,152  0,061  Anesthetic
0,102  0,012  Antimycoplasmal
0,198  0,110  Antihypotensive
0,144  0,059  Farnesoid X receptor antagonist
0,129  0,045  Transcription factor STAT6 inhibitor
0,144  0,061  Tubulin antagonist
0,224  0,143  GST M1-1 substrate
0,103  0,022  Estrogen-related receptor beta agonist
0,120  0,039  HIV-1 integrase (Overall Integration) inhibitor
0,154  0,074  Antimutagenic
0,177  0,098  VEGF expression inhibitor
0,186  0,107  VCAM1 expression inhibitor
0,210  0,133  CYP2D6 substrate
0,176  0,100  Insulin sensitizer
0,124  0,047  HDL-cholesterol increasing
0,131  0,055  Sphingosine 1-phosphate receptor 4 antagonist
0,107  0,032  Antibiotic
0,181  0,107  Ca2+/calmodulin-dependent kinase I alpha inhibitor
0,171  0,097  CYP2B6 inhibitor
0,142  0,068  Ca2+-transporting ATPase inhibitor
0,095  0,024  Beta tubulin antagonist
0,119  0,051  Expectorant
0,101  0,033  Granulocyte macrophage colony stimulating factor agonist
0,152  0,085  Antihelmintic (Nematodes)
0,102  0,035  Xanthine oxidase substrate
0,075  0,009  Pregnane X receptor antagonist
0,144  0,079  Antidiarrheal
0,189  0,125  DNA damaging
0,075  0,012  Squalene epoxidase inhibitor
0,131  0,068  Alpha-N-acetylglucosaminidase inhibitor
0,177  0,115  Glucose-6-phosphate dehydrogenase-6-phosphogluconolactonase inhibitor
0,095  0,033  Glutamate dehydrogenase inhibitor
0,170  0,108  Glyceraldehyde-3-phosphate dehydrogenase inhibitor
0,093  0,032  GABA aminotransferase inhibitor
0,127  0,066  Papain-like protease (SARS coronavirus) inhibitor
0,214  0,156  ICAM1 expression inhibitor
0,073  0,015  Estradiol 17 beta-dehydrogenase inhibitor
0,085  0,027  Peroxisome proliferator-activated receptor gamma antagonist
0,114  0,058  Carcinogenic, group 2B
0,102  0,046  SULT1E1 substrate
0,137  0,081  Antianorexic
0,229  0,173  Histamine release inhibitor
0,082  0,027  Aromatase inhibitor
0,100  0,046  Androgen antagonist
0,196  0,143  Tyrosine 3 hydroxylase inhibitor
0,074  0,021  Heme oxygenase stimulant
0,091  0,040  Na+ K+ transporting ATPase inhibitor
0,112  0,061  Choleretic
0,087  0,037  Phosphofructokinase-1 inhibitor
0,127  0,078  Alkaline phosphatase inhibitor
0,137  0,090  Antiviral (Herpes)
0,109  0,063  Antiviral (Coronavirus)
0,109  0,063  Antiviral (SARS coronavirus)
0,082  0,036  Glycine receptor agonist
0,113  0,067  Photosensitizer
0,073  0,030  Purinergic P2X1 antagonist
0,078  0,035  Anticholelithogenic
0,095  0,053  Triose-phosphate isomerase inhibitor
0,097  0,056  Alcohol dehydrogenase inhibitor
0,216  0,176  Antiprotozoal (Plasmodium)
0,067  0,028  Botulinum neurotoxin type A inhibitor
0,174  0,136  Immunostimulant
0,093  0,057  Thioredoxin inhibitor
0,060  0,024  Glucose-6-phosphate translocase inhibitor
0,050  0,015  Inosine monophosphate dehydrogenase inhibitor
0,047  0,015  Retinoid X receptor antagonist
0,050  0,018  Retinoid X receptor agonist
0,077  0,045  Histidine decarboxylase inhibitor
0,086  0,055  Vanilloid agonist
0,043  0,011  HMG CoA reductase inhibitor
0,039  0,009  Estradiol 17 beta-dehydrogenase 1 inhibitor
0,048  0,019  Alpha 1L adrenoreceptor agonist
0,085  0,056  3C-Like protease (SARS coronavirus) inhibitor
0,116  0,088  Antibacterial (Helicobacter pylori)
0,058  0,030  Dihydroorotate dehydrogenase inhibitor
0,106  0,080  Cholesterol synthesis inhibitor
0,090  0,064  Uric acid excretion stimulant
0,092  0,067  Bile acid receptor antagonist
0,042  0,018  Retinoid X alpha receptor agonist
0,051  0,028  Cholesterol esterase inhibitor
0,062  0,041  TRPA1 antagonist
0,196  0,175  Caspase 3 stimulant
0,076  0,055  Keratolytic
0,055  0,034  Acetyl-CoA transferase inhibitor
0,127  0,107  Hexokinase inhibitor
0,052  0,034  Thromboxane A2 antagonist
0,023  0,005  Thyroid hormone alpha agonist
0,030  0,013  Thyroid hormone agonist
0,059  0,042  Heat shock protein 90 beta antagonist
0,034  0,018  Glutamate (mGluR3) agonist
0,034  0,018  ATP citrate lysase inhibitor
0,086  0,072  Prolactin inhibitor
0,079  0,065  Thioredoxin reductase inhibitor
0,117  0,103  Peroxidase inhibitor
0,035  0,022  Retinoid X alpha receptor antagonist
0,055  0,042  Xanthine dehydrogenase inhibitor
0,095  0,083  Cystathionine beta-synthase inhibitor
0,020  0,008  Thyroid hormone alpha antagonist
0,073  0,061  Antitreponemal
0,051  0,040  Thromboxane antagonist
0,049  0,038  CD45 antagonist
0,035  0,024  Estradiol 17 beta-dehydrogenase 2 inhibitor
0,141  0,131  Antimitotic
0,090  0,079  Urease inhibitor
0,019  0,009  Calcium-sensing receptor antagonist
0,047  0,037  Estrogen agonist
0,026  0,016  Vanilloid 2 agonist
0,158  0,149  Cardiovascular analeptic
0,086  0,078  Creatine kinase inhibitor
0,021  0,014  Retinoid X beta receptor antagonist
0,069  0,063  Topoisomerase II alpha inhibitor
0,160  0,154  Spasmolytic
0,041  0,036  Geranyltranstransferase inhibitor
0,205  0,202  GABA C receptor rho-3 antagonist
0,023  0,020  Sodium/glucose cotransporter 1 inhibitor
0,015  0,013  Antibiotic Tetracycline-like
0,025  0,024  Retinoid X gamma receptor antagonist
0,024  0,023  Sodium/glucose cotransporter 2 inhibitor
0,176  0,175  Transcription factor STAT inhibitor

